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The treatment of obesity requires creating an energy deficit through caloric restriction and
physical activity. Energy needs are estimated assessing the resting energy expenditure
(REE) that in the clinical practice is estimated using predictive equations. In the present
cross sectional study, we compared, in a large cohort of morbidly obese patients,
the accuracy of REE predictive equations recommended by current obesity guidelines
[Harris-Benedict, WHO/FAO/ONU and Mifflin-St Jeor (MJ)] and/or developed for obese
patients (Muller, Muller BC, Lazzer, Lazzer BC), focusing on the effect of comorbidities on
the accuracy of the equations. Data on REE measured by indirect calorimetry and body
composition were collected in 4,247 obese patients (69% women, mean age 48 ± 19
years, mean BMI 44± 7 Kg/m2) admitted to the Istituto Auxologico Italiano from 1999 to
2014. The performance of the equations was assessed in the whole cohort, in 4 groups
with 0, 1, 2, or ≥ 3 comorbidities and in a subgroup of 1,598 patients with 1 comorbidity
(47.1% hypertension, 16.7% psychiatric disorders, 13.3% binge eating disorders, 6.1%
endocrine disorders, 6.4% type 2 diabetes, 3.5% sleep apnoea, 3.1% dyslipidemia, 2.5%
coronary disease). In the whole cohort of obese patients, as well as in each stratum
of comorbidity number, the MJ equation had the highest performance for agreement
measures and bias. TheMJ equation had the best performance in obese patients with≥3
comorbidities (accuracy of 61.1%, bias of −89.87) and in patients with type 2 diabetes
and sleep apnoea (accuracy/bias 69%/−19.17 and 66%/−21.67 respectively), who also
have the highest levels of measured REE. In conclusion, MJ equation should be preferred
to other equations to estimate the energy needs of Caucasian morbidly obese patients
when measurement of the REE cannot be performed. As even MJ equation does not
precisely predict REE, it should be better to plan the diet intervention by measuring rather
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than estimating REE. Future studies focusing on the clinical differences that determine
the high inter-individual variability of the precision of the REE predictive equations (e.g.,
on the organ-tissue metabolic rate), could help to develop predictive equations with a
better performance.
Keywords: resting energy expenditure, indirect calorimetry, comorbidities, REE predictive equations, obesity
INTRODUCTION
The treatment of obesity requires creating an energy deficit
through caloric restriction, physical activity, or both (1). The
energy needs are based on the resting energy expenditure
(REE) which is the major component of the total daily energy
expenditure and reflects the energy required to maintain the vital
functions at resting state. The major determinant of the REE is
the fat- free mass (FFM), which is composed by the sum of two
moieties, one with a high metabolic rate (skeletal muscle and
visceral organs accounts for 16 and 84% of REE respectively) and
one with a low metabolic rate (bone and extracellular mass) (2).
Early studies suggested that obesity is due to a predisposition
to a lower REE that contributes with sedentary lifestyles to
a positive energy balance (3). Conversely, subsequent studies
demonstrated that REE levels are high in non-sarcopenic obese
individuals because the body weight increase is associated with a
concomitant increase in fat mass (FM) and FFM, and the FM also
is an independent predictor of REE with greater effect in subjects
with higher FM amount (3). Although it has not been established
with certainty what the FFM compartment is the main predictor
of REE in obese subjects, some studies support a greater role
for the visceral component than muscular mass (2). The REE
is commonly measured with indirect calorimetry (4), which
however it is not used in the majority of outpatients because it
is expensive and time consuming. Thus, in the clinical practice
energy needs are estimated using REE predictive equations based
on body weight, height, age and sex and/or body composition
parameters. Several predictive equations have been proposed in
the last century, however current guidelines for the management
of obesity still recommend equations developed more than 30
years ago (Harris Benedict 1984, the FAO/WHO/ONU 1985)
on populations definitely different from the nutritional point
of view from the current ones (5, 6). Since the evidence that
the application of Harris Benedict 1984 and FAO/WHO/ONU
1985 for determining REE in overweight/obese subjects tends to
overestimate the true metabolic rate, the Academy of Nutrition
and Dietetics recommends the use of the Mifflin-St Jeor equation
in obese individuals (7–9). In a large cohort of obese subjects free
ofmetabolic or endocrine diseases such as diabetes, hypertension,
and hypothyroidism, Lazzer et al developed predictive equations
based on age, sex and FFM finding that the measured REE was
correctly predicted in 56% of adult subjects. The authors also
reported that the accuracy of the predictive equation was not
improved by the inclusion of FM in the formula (10).
A very recent external validation of REE predictive equations
reported that the accuracy of the formulas decreases going from
normal-weight to class 3 obesity (11). This suggests that in
morbid obesity, there are factors affecting the REE that are
not captured by the available equations. Considering that the
probability of having multiple comorbidities increases with the
degree of obesity, it could be hypothesized that one of the factors
that affects the predictive capacity of the equations is linked to
the altered metabolic rate of organs compromised by specific
pathologies. In this regard, the REE is altered in patients with
cardio-metabolic diseases such as type 2 diabetes, hypertension
and sleep apnoea (12–14). For this reason, Huang et al. included
a correction factor in a predictive equation specific for patients
with type 2 diabetes (14).
In the present cross sectional study, we compared in a
large cohort of morbidly obese patients, the accuracy of REE
predictive equations recommended by current guidelines and/or
developed for obese patients, focusing on the presence and type
of comorbidity.
MATERIALS AND METHODS
Study Design and Participants
A cross sectional study was carried out on 4,247 adult
Caucasian obese and morbidly obese patients admitted for a
weight loss intervention from 1999 to 2014 at the IRCCS
Istituto Auxologico Italiano, Piancavallo (Verbania, Italy).
Patients were selected for being admitted for a weight
loss intervention, being free of acute diseases and having
a physiologic Respiratory Quotient (RQ between 0.71 and
1.0) during the indirect calorimetry measurement performed
before the weight loss intervention. The following parameters
were collected: age, sex, height, weight, FM, FFM, and
REE assessed by indirect calorimetry, and the presence
comorbidities (hypertension, type 2 diabetes, coronary disease,
dyslipidemia, sleep apnoea, endocrine disorders psychiatric
disorders and binge eating disorder). The IRCCS Istituto
Auxologico Italiano Ethics Committee (https://www.auxologico.
it/ricerca-formazione/comitato-etico, Via Ariosto 13, Milano,
Italy, e-mail: comitato.etico@auxologico.it) approved the study
and all subjects involved were informed and gave their signed
consent to use data for research purposes.
Indirect Calorimetry and Body Composition
The REE was measured in the morning between 8 and 9 a.m.
after a fasting period of 12 h in thermoneutral conditions (in
a 22–25◦C room) by an open-circuit, indirect computerized
calorimetry (Vmax 29, Sensor Medics, Yorba Linda, CA, USA)
which is periodically subjected to quality controls to ensure
the reliability of the measures. The flow sensor calibration
was completed daily after at least 30min of warm up of
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TABLE 1 | REE predictive equations used in the present study.
Harris Benedict 1984
(kcal/day)
Male
88.362 + 4.799*height (cm) + 13.397*weight (kg)
− 5.677*age
Female
447.593 + 3.098*height (cm) +9.247*weight (kg)
− 4.330*age
Huang
(kcal/day)
71.767 − 2.337*age + 257.293*sex (M = 1; F =
0) + 9.996*weight (Kg)
+ 4.132*height (cm) + 145.950*DM (non-diabetic
= 0; diabetic = 1)
Mifflin-St Jeor
(Kcal/day)
9.99*weight (Kg) + 6.25*height (cm) − 4.92*age
+ 166*sex (M = 1; F = 0) −161
Lazzer 2010
(kcal/day)
11*kg − 3*age + 272*sex (M = 1; F = 0) + 777
Lazzer BC 2010
(Kcal/day)
20*FFM (kg) − 2*age − 11*sex (F = 0; M = 1) +
841
Muller (BMI ≥ 30)
(MJoule/day)
0.05*weight (kg) + 1.103*sex (F = 0; M = 1) −
0.01586*age + 2.924
Muller BC (BMI ≥ 30)
(MJoule/day)
0.05685*FFM (kg) + 0.04022*FM (kg) +
0.808*sex − 0.01402*age + 2.818
FAO/WHO/ONU
(Kcal/day)
Male
18–30 yrs 15.4*weight (Kg)−27*height (m) + 717
30–60 yrs 11.3*weight (Kg) + 16*height (m) + 901
≥60 yrs 8.8 *weight (Kg) + 1,128*height (m) −
1,071
Female
18–30 yrs 13.3*weight + 334*height (m) + 35
30–60 yrs 8.7*weight − 25*height (m) + 865
≥60 yrs 9.2*weight + 637*height (m) − 302
the Vmax calorimeter prior to measurement session. On each
testing day, the calorimeter performed two calibration points
using two reference gas mixtures (15% O2/5%CO2 and 26%
O2/0%CO2) and the calibration of the environmental gases,
allowing measuring the physiological range of the inspired
and exhaled volumes. Subjects were physically inactive for at
least 12 h and not smoking from at least 8 h. Subjects were
awake and in supine position with the head placed in a
rigid, transparent ventilated canopy. The respiratory exchange
was measured for 30min or until the steady state (defined
as no variations higher than 5% during 5 consecutive min)
had been reached. Data of the 10min acclimation period were
discarded. Minute-by-minute measurements of CO2 (mL/min)
expired and, O2 consumed (mL/min) and RQ (VCO2/VO2)
were recorded. The REE was calculated using the Weir equation
[Kcal/d=1.44∗(3.94VO2+1.11VCO2)].
The body composition was assessed by the bioelectrical
impedance analysis (BIA 101 Anniversary, Akern, Florence
Italy), in the morning after an overnight fast and no more than
2 days later the execution of the indirect calorimetry.
REE Predictive Equations
The REE predictive equations used in this study are reported
in Table 1. We choose the equations recommended for
TABLE 2 | Sociodemographic and clinical characteristics of the whole sample of
4,247 obese patients.
Variable
Age, years 47.66 ± 13.85
Male, n (%) 1,300 (31%)
Weight, kg 117.80 ± 24.03
Height, cm 162.79 ± 9.83
BMI, kg/m2 44.33 ± 7.46
BMI classes, n (%):
30–35 319 (8%)
35–40 868 (20%)
40–45 1,302 (31%)
≥45 1,758 (41%)
Fat free mass, kg 63.6 ± 18.44
Fat mass, kg 56.3 ± 18.17
Concomitant diseases, n (%) 3,242 (76)
Hypertension, n (%) 2,095 (49)
Type 2 diabetes, n (%) 939 (22)
Coronary disease, n (%) 260 (6)
Dyslipidemia, n (%) 638 (15)
Sleep apnoea, n (%) 576 (14)
Endocrine disorders, n (%) 262 (6)
Psychiatric disorders, n (%) 597 (14)
Binge eating disorder, n (%) 438 (10)
REE measured, kcal/day 1875.41 ± 430.16
FAO/WHO/ONU, kcal/day 1989.8 ± 402.75
Harris Benedict 1984, kcal/day 1986.61 ± 412.97
Huang, kcal/day 1921.63 ± 362.92
Lazzer 2010, kcal/day 2013.14 ± 348.87
Lazzer BC 2010, kcal/day 2015.08 ± 371.84
Mifflin-St Jeor, kcal/day 1849.61 ± 346.88
Muller, kcal/day 2006.7 ± 370.96
Muller BC, kcal/day 1979.3 ± 431.03
Data are expressed as mean ± SD or percentage.
overweight and obese subjects by national and international
guidelines and/or developed in large cohorts of obese individuals
(5–10, 14–16).
Statistical Analyses
Sociodemographic and clinical continuous variables were
expressed as means ± standard deviation (SD) and categorical
data as frequencies and proportions. The agreement between
measured REE (reference) and REE obtained by the predictive
equations was analyzed both graphical visualizations (limits of
agreement, LOA) in the Bland-Altman plot (17) and several
indices (accuracy, bias, concordance correlation coefficient,
CCC, and Mean squared Deviation, MSD) (18). In brief, for
each predictive equation, the Bland-Altman plot compares the
predicted with the measured REE. Specifically, the comparison
consists to plot the differences between the predicted REE and
the measured REE on y-axis and the reference on x-axis (19).
The LOA reported in the Bland-Altman plot give the range
of discordance between predicted and reference that, with a
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FIGURE 1 | Bland-Altman plots displaying the agreement between measured REE and the REE predicted by eight predictive equations (A) WHO/FAO/ONU, (B)
Harris Benedict 1984, (C) Huang, (D) Lazzer 2010, (E) Lazzer BC 2010, (F) Mifflin-St Jeor, (G) Muller, (H) Muller BC equations. Continuous lines indicate the value of
the difference equal to 0 that means that the REE predicted coincides with REE measured. Dotted lines indicate the level of agreement of predicted and measured
REE. Pointed lines indicate the mean of the differences between predicted and measured REE (bias).
confidence of 1-α, comprises the true value of discordance. The
accuracy is the proportion of patients in which the predicted REE
falls in the range of acceptability (±10% of the measured REE).
The bias is the mean of the differences between predicted
and measured REE; positive values suggest overestimates
of the measurements obtained by the considered specific
predictive equation and negative values suggest the opposite. The
Concordance Correlation Coefficient (CCC), varying between
0 and 1, measures the concordance between the predicted and
measured REE. Finally the Mean Squared Deviation (MSD)
represents the expectation of the squared difference between
predicted and measured REE, with low values suggesting good
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agreement. All analyses were performed in the entire sample
and in specific subgroups defined by number and type of
comorbidities. Chi square and trend tests were used to test
the differences between subgroups. All analyses were performed
using SAS version 9.4 software (SAS Institute, Cary, NC, USA).
RESULTS
The Table 2 describes the clinical characteristics of the cohort
of 4,247 obese patients considered in the sample. Seventy
eight percent of patients had a concomitant disease. Psychiatric
diseases included personality disorders, anxiety and obsessive-
compulsive and phobic disorders. Most of endocrine diseases
(70%) were represented by hypothyroidism, on L-thyroxin
treatment, or subclinical hypothyroidism.
Figure 1 shows the Bland-Altman plots for all predictive
equations. The Mifflin-St Jeor equation had the lowest value of
bias index which provides a mean measure of the overestimation
or the underestimation of the specific equation compared to
the measured REE (−25.80 kcal/day). These results fitted with
the other agreement measures (accuracy, CCC and MSD), as
reported in Table 3. The CCC of Mifflin-St Jeor equation was
close to 80% with lowest value of MSD and the higher value of
accuracy (56.18%). The accuracy of the Mifflin-St Jeor equation
increases significantly in the tertiles of BMI (51.47, 57.93, and
58.08% in BMI <40, 40–45.9, and >46 kg/m2 respectively, p
< 0.001 for trend). Separation by sex and age tertiles did not
affect the accuracy of Mifflin-St Jeor equation.When we stratified
the sample by the number of comorbidities, 4 groups were
considered (0, 1, 2, or ≥ 3 comorbidities). The proportion of
patients of each group was 24, 38, 22, and 16%. Body mass
index, measured REE and age (41.7 ± 13.7, 46.5 ± 13.9, 50.5
± 12.6, and 55.3 ± 10.7 years, p < 0.001) increased from the
group with 0 to the group with ≥3 comorbidities (Table 4).
This finding was similar in the two sexes (data not shown). The
accuracy of each predictive equation significantly improved with
the increase in the number of comorbidities (p< 0.0001 for trend
for each equation except for the Huang equation which was not
significant). In each stratum, the Mifflin-St Jeor equation showed
the higher performance for both agreement measures and bias
(Table 5). In the more complicated obese patients, the Muller
BC equation had a performance similar to the Mifflin-St Jeor
equation (Table 5).
To verify whether the performance of the predictive equations
was comorbidity-dependent, we measured the accuracy of the
equations in 1,598 patients with only one comorbidity. Forty
seven percent of them had hypertension, 16.7% psychiatric
disorders, 13.3% binge eating disorders, 6.1% endocrine
disorders, 6.4% type 2 diabetes, 3.5% sleep apnoea, 3.1%
dyslipidaemia and 2.5% coronary disease (Table 4). The Mifflin-
St Jeor equation had the highest performance values in patients
with type 2 diabetes and sleep apnoea (accuracy/bias 69%/−19.17
and 66%/−21.67 respectively) (Table 6) who were also those
with the highest levels of measured REE (Table 4).
The accuracy of Mifflin-St Jeor equation was significantly
higher in diabetic than in non-diabetic patients (68.93 vs. 53.11%,
TABLE 3 | Comparison of predicted with measured REE.
Accuracy (%) Bias CCC MSD
(P-M) %*
FAO/WHO/ONU 47.12 114.39 6.1 0.75 89042.44
Harris Benedict 1984 49.28 111.20 5.9 0.78 79953.23
Huang 53.83 46.22 2.5 0.79 65021.93
Lazzer 2010 46.08 137.73 7.3 0.75 80354.97
Lazzer BC 2010 44.69 139.67 7.4 0.67 112628.42
Mifflin-St Jeor 56.18 −25.80 −1.4 0.79 63113.78
Muller 46.86 131.29 7.0 0.77 78981.30
Muller BC 49.12 103.89 5.5 0.74 97616.05
CCC, Concordance Correlation Coefficient; MSD, Mean Squared Deviation; BC, Body
composition; P, REE predicted; M, REE measured; *Mean difference percentage
calculated as the mean difference between REE predicted and REE measured divided
by the mean of REE measured.
TABLE 4 | Values of measured REE and BMI according to the number and type of
comorbidity.
Number of
comorbidities
N
subjects
Measured REE
(kcal.day−1)
BMI
(kg/m2)
0 1,005 1782.2 ± 405.09 42.1 ± 6.7
1 1,598 1845.7 ± 420.98 43.9 ± 7.7
2 955 1940.1 ± 434.55 45.9 ± 7.5
≥3 689 1990.7 ± 442.06 46.5 ± 6.9
p-value trend <0.0001 <0.001
Type of comorbidity for
patients with only 1
comorbidity
Hypertension 754 1841.6 ± 427.26 44.41 ± 7.90
Psychiatric disorders 267 1791.6 ± 383.11 42.45 ± 7.77
Binge eating disorders 213 1821.1 ± 388.96 42.59 ± 6.88
Endocrine disorders 114 1681.0 ± 328.20 42.40 ± 6.65
Type 2 Diabetes 103 2059.4 ± 413.07 46.30 ± 5.91
Sleep Apnoea 56 2194.9 ± 469.10 49.20 ± 8.87
Dyslipidemia 50 1879.5 ± 453.43 42.71 ± 6.27
Coronary disease 41 1803.4 ± 418.85 41.32 ± 7.63
p < 0.01) after adjustment for BMI, age and sex obtained by log-
binomial regression model. This was observed also for patients
with sleep apnoea where the accuracy was 66.07% compared
to 33.93% in patients without sleep apnoea (p = 0.0597 after
adjustment for BMI, age and sex).
DISCUSSION
Results of our study suggest that Mifflin-St Jeor equation has
the highest performance for both accuracy and bias, particularly
in patients with more severe and complicated obesity. The best
accuracy of the Mifflin-St Jeor equation was recorded in patients
with type 2 diabetes and sleep apnoea, whereas this formula
has a very low accuracy in patients with hypertension who
represent the largest percentage of the obese population. It must
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TABLE 5 | Comparison of predicted with measured REE according to the number of comorbidity.
Number of
comorbidities
Accuracy (%) Bias CCC MSD
(P-M) %*
0 (N = 1,005) FAO/WHO/ONU 39.60 181.47 11.84 0.72 101766.30
Harris Benedict 1984 43.28 154.77 10.34 0.75 85548.99
Huang 51.74 49.07 4.58 0.79 59539.87
Lazzer 2010 40.70 170.55 11.74 0.72 85803.17
Lazzer BC 2010 36.12 202.58 13.82 0.62 134676.82
Mifflin-St Jeor 51.74 28.22 3.34 0.79 59325.23
Muller 41.69 163.38 11.10 0.73 84119.36
Muller BC 41.19 143.42 9.36 0.71 111088.29
1 (N = 1,598) FAO/WHO/ONU 44.49 125.90 8.75 0.72 95909.49
Harris Benedict 1984 47.37 114.46 7.96 0.76 83854.69
Huang 53.13 30.11 3.55 0.77 66744.29
Lazzer 2010 43.99 143.20 10.03 0.73 85078.00
Lazzer BC 2010 41.43 174.45 11.97 0.63 131743.88
Mifflin-St Jeor 54.13 −12.12 1.20 0.77 65840.58
Muller 44.49 136.66 9.45 0.74 83757.19
Muller BC 44.81 135.80 8.91 0.71 113600.30
2 (N = 955) FAO/WHO/ONU 52.98 78.37 5.45 0.79 77409.69
Harris Benedict 1984 53.61 86.04 5.56 0.81 73905.39
Huang 56.34 37.98 3.49 0.81 64472.79
Lazzer 2010 50.58 116.40 7.79 0.79 72064.48
Lazzer BC 2010 51.20 84.33 6.30 0.75 85019.39
Mifflin-St Jeor 60.73 −59.30 −1.72 0.81 60849.02
Muller 50.68 111.66 7.32 0.80 71655.95
Muller BC 55.71 66.97 4.71 0.79 80940.12
≥3 (N = 689) FAO/WHO/ONU 56.02 39.75 3.49 0.80 70990.02
Harris Benedict 1984 56.46 74.98 4.96 0.82 71411.12
Huang 55.01 90.85 6.26 0.79 70053.12
Lazzer 2010 52.54 106.74 7.27 0.78 73206.67
Lazzer BC 2010 55.73 43.98 4.30 0.76 74767.81
Mifflin-St Jeor 61.10 −89.87 −3.15 0.80 65711.27
Muller 54.57 99.22 6.67 0.80 70826.07
Muller BC 61.54 23.37 2.85 0.80 64353.62
*Mean difference percentage calculated as the mean difference between REE predicted and REE measured divided by the mean of REE measured. CCC, Concordance Correlation
Coefficient; MSD, Mean Squared Deviation; BC, Body composition; P, REE predicted; M, REE measured.
be emphasized, however, that the accuracy of the Mifflin-St Jeor
equation is far from being an ideal tool to correctly predict
REE, leading to the conclusion that in obese individuals, it is
better to plan a diet intervention by measuring rather than
estimating the REE. In this regard, a dietary program set on
the REE measured with the indirect calorimetry was shown to
be more effective than based on the Harris Benedict equation
in promoting weight loss in overweight or obese subjects (20).
It would be interesting in the future to verify the efficacy of
nutrition plans based on the Mifflin-St Jeor equation. Our results
support the use of the Mifflin-St Jeor equation when the indirect
calorimeter is unavailable, as recommended by the Academy
of Nutrition and Dietetics for obese individuals (8, 9). This
equation allows reducing the error brought by using the Harris-
Benedict and FAO/WHO/ONU formulas that are still the most
used formulas in the clinical practice regardless of the subject’s
phenotype. In agreement, a recent systematic literature reviews
concluded that the Mifflin-St Jeor equation gives the most
acceptable REE prediction in obese subjects (21). We observed
that the performance of the formulas and in particular of Mifflin-
St Jeor equation improves with the increase in the number
of comorbidities, which was also associated with the increase
in BMI and energy needs. The more likely hypothesis for the
good performance of Mifflin St-Jeor equation is that the RENO
Diet-Heart cohort of obese individuals in whom this equation
was developed, though described as healthy (7), probably had
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4 similar, but under evaluated, chronic comorbidities than our
cohort.
In conditions with highest energy needs such as obese
individuals with≥3 comorbidities and type 2 diabetes, theMuller
BC equation had an accuracy similar to that of Mifflin-St Jeor
equation likely because it takes into account the FM, whose
inflammation may increase energy requirements.
Though BMI may be the major determinant of energy
needs, specific pathologies seem to influence the measured REE
at similar levels of BMI. This finding suggests that specific
comorbidities may be accompanied by alterations of the organ
metabolic rate/functional mass that modify the energy needs in
a way not currently predicted by the equations. It is difficult
to ascertain how much a greater measured REE contributes to
improvement in the accuracy of the predictive equations, because
REE, BMI and clinical severity are parameters highly interrelated.
Alternatively, as all equations are based on a linear regression
model, it is possible that mathematical reasons justify the parallel
increase in the accuracy of the formulas and the measured
REE. Since even the application of an artificial neural network
did not allow to substantially improve the REE prediction in
obese subjects (22), it would be more appropriate to change the
approach when prescribing a diet, considering also the ability to
mobilize the energy stores over the time rather than the energy
demand at rest (23).
The strength of our study is that it was conducted in a
large sample of unselected obese patients characterized for type
and number of comorbidities representing the more frequent
condition in which energy requirements are estimated. Several
limitations of the study must be underlined. First, the sample
was composed by a homogeneous ethnic group of Caucasian
origin and whether formulas perform similarly in other ethnic
groups should be verified. Second, we did not collect information
on the ongoing pharmacological therapy, and thus we cannot
distinguish the effect of comorbidities from that of the associated
pharmacological therapy. This should be assessed in future
studies.
In conclusion, the Mifflin-St Jeor equation, though far from
being an ideal tool to precisely predict the REE, should be
preferred to other equations to estimate the energy needs of
Caucasian morbidly obese patients when the measurement of
REE cannot be implemented.
Future studies focusing on the clinical differences that
determine the high inter-individual variability of the precision of
the REE predictive equations (e.g., on the organ-tissue metabolic
rate), could help to develop predictive equations with a better
performance.
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